United Kingdom · Investor

LifeArc Ventures

Last cheque observed Jun 2026; 8 cheques on record.

Deploying nowVC firm

SeedSeries BVenture Capital & Private Equity

Deploying now
67%of best year2cheques in 12 months, 8 on record
Since the last cheque129days00hrs00min00sec
Median round$93MRounds led2 of 8Mostly inUnited States, 50%
Pitch LifeArc Ventures

LifeArc Ventures highlights

  1. 01

    2 cheques in the last 12 months

  2. 02

    Mostly Series A and Series B: 100% of its rounds

  3. 03

    Led 2 rounds

What they do

Type
VC firm (from a list, unverified)
Cheque size
Not stated
Stages
SeedSeries B
Sectors
Venture Capital & Private Equity
Based in
London, United Kingdom
Cold pitches
Not stated

The record

Every round we can evidence, newest first8 appearances

  1. 2026

    2 rounds

  2. Jun
    RQ BioSeries A · GB · Frazier Life Sciences$115MWith 7 others
  3. May
    Cytospire TherapeuticsSeries A · GB · Ventureburn$83MWith 9 others
  4. 2025

    2 rounds

  5. May
    GlycoEraSeries B · CH · TechStartups$130MWith 8 others
  6. Mar
    Hillstar BioSeries A · US · Firms' own news pages$67MWith 5 others
  7. 2024

    1 round

  8. Oct
    OzloUS · TechCrunch$12MLed
  9. 2019

    2 rounds

  10. Apr
    SpringWorks TherapeuticsSeries B · US · FinSMEs$125MWith 12 others
  11. Mar
  12. 2017

    1 round

  13. Sept
    SpringWorksSeries A · US · FinSMEs$103MWith 4 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

The team

We hold 5 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

What they claim to have backed

From their own portfolio page (on their website)

14 of 19 we have independently watched raise

Affect TherapeuticsAviadoBioClimb BioCorteria PharmaceuticalsCumulus NeuroscienceCytospire TherapeuticsExcivaFluid BiomedGlycoEraHillStar BioIkarovecMaxion TherapeuticsOZLO SleepRQ BIOCookiedatabaseMC SciencesPheno TherapeuticsPitcher & CrowT-Cypher Bio

Weaker than a round we watched, stronger than a list somebody sold us. A firm is far less willing to put a company on its own site that it never funded.

Who they invest alongside

The investors most often in the same rounds as LifeArc Ventures. A count of rooms they were both in, not a relationship either has claimed.

Recently backed

The latest companies LifeArc Ventures put money into.

Quick answers about LifeArc Ventures

What does LifeArc Ventures invest in?

LifeArc Ventures invests most often at Series A and Series B (100% of the rounds on record), in sectors such as Venture Capital & Private Equity.

How active is LifeArc Ventures?

8 investments on record, 2 of them in the last 12 months, and it led 2. The most recent was in Jun 2026.

What has LifeArc Ventures invested in recently?

Its most recent investments on record: RQ Bio (Series A, Jun 2026), Cytospire Therapeutics (Series A, May 2026) and GlycoEra (Series B, May 2025).

How big are LifeArc Ventures's cheques?

The median round it joins is $93M.

Does LifeArc Ventures lead rounds?

Yes: it led 2 of its 8 investments on record (25%).

Where does LifeArc Ventures invest?

Most of the companies it backs are in the United States (50%), the United Kingdom (38%) and Switzerland (13%).

Is LifeArc Ventures investing now?

Yes: it is actively investing, with 2 investments in the last 12 months.

Who does LifeArc Ventures invest alongside?

Most often Frazier Life Sciences (2 rounds together), Modi Ventures (2 rounds together) and Novo Holdings (2 rounds together).

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it